Some synthetic dextran derivatives that mimic the action of heparin/heparan
sulfate were shown to promote in vivo tissue repair when added alone to wo
unds. These biofunctional mimetics were therefore designated as "regenerati
ng agents" in regard to their in vivo properties. In vitro, these biopolyme
rs were able to protect various heparin-binding growth factors against prot
eolytic degradation as well as to inhibit the enzymatic activity of neutrop
hil elastase. In the present work, different dextran derivatives were teste
d for their capacity to inhibit the enzymatic activity of human plasmin. We
show that dextran containing carboxymethyl, sulfate as well as benzylamide
groups (RG1192 compound), was the most efficient inhibitor of plasmin amid
olytic activity. The inhibition of plasmin by RG1192 can be classified as t
ight binding hyperbolic noncompetitive. One molecule of RG1192 bound 20 mol
ecules of plasmin with a K-i of 2.8 x 10(-8) M. Analysis with an optical bi
osensor confirmed the high affinity of RG1192 for plasmin and revealed that
this polymer equally binds plasminogen with a similar affinity (K-d = 3 x
10(-8) M), Competitive experiments carried out with 6-aminohexanoic acid an
d kringle proteolytic fragments identified the lysine-binding site domains
of plasmin as the RG1192 binding sites. In addition, RG1192 blocked the gen
eration of plasmin from Glu-plasminogen and inhibited the plasmin-mediated
proteolysis of fibronectin and laminin, Data from the present in vitro inve
stigation thus indicated that specific dextran derivatives can contribute t
o the regulation of plasmin activity by impeding the plasmin generation, as
a result of their binding to plasminogen and also by directly affecting th
e catalytic activity of the enzyme.